Table 1 Patients’ characteristics at the time of surgery (n = 24)
From: Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC
Mean | Range | |
|---|---|---|
Age (years) | 65.29 | 47–78 |
Sex | Frequency | % |
Male | 14 | 58.3 |
Female | 10 | 41.7 |
Histologic type | Frequency | % |
Adenocarcinoma | 22 | 91.7 |
Squamous cell | 2 | 8.3 |
Surgery | Frequency | % |
Lobectomy | 20 | 83.5 |
Sublobar resection | 4 | 16.5 |
Lymphadenectomy | Frequency | % |
Yes | 21 | 87.5 |
No | 3 | 12.5 |
pT stage | Frequency | % |
pT1 | 9 | 37.5 |
pT2 | 11 | 45.8 |
pT3 | 1 | 4.2 |
pT4 | 3 | 12.5 |
pN stage | Frequency | % |
pN0 | 17 | 70.8 |
pN1 | 6 | 25.0 |
pN2 | 1 | 4.2 |
TNM Classification 8th Ed | ||
I | 6 | 25.0 |
IIA | 5 | 20.8 |
IIB | 8 | 33.4 |
IIIA | 5 | 20.8 |
(Neo)Adjuvant treatment at the time of surgery | ||
None | 16 | 66.6 |
Adjuvant | 4 | 16.7 |
Neoadjuvant | 4 | 16.7 |